1984 Jun
Acknowledgements Funding This review and the article processing charges were funded by Eli Lilly Australia
Originally developed to regulate blood sugar in people with diabetes, GLP-1 treatments have been clinically proven to also support significant, sustained weight loss
Across preclinical research, BPC-157 has been reported to have a favorable tolerability profile: a 2021 Frontiers in Pharmacology review noted no reported toxicity in animal studies, with the LD1 (lethal dose for 1% of animals) not reached
Theres not enough scientific evidence or research, though, to know about long-term side effects, since the studies have been small and short-term
Ginkgo biloba also has anti-inflammatory properties, reducing cyclooxygenase activity and decreasing IL-8 and vascular endothelial growth factor release in response to TNF- [108]